Patents by Inventor Miryam Terzano
Miryam Terzano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11771102Abstract: The present invention features compositions and methods for modulation of the mucosal immune system. The compositions include foods fermented by the probiotic organism, Lactobacillus paracasei CBA L74 (International Depository Accession Number LMG P-24778). Alternatively the compositions can include L. paracasei CBA L74 and a physiologically acceptable carrier. In some embodiments, the L. paracasei CBA L74 can be non-replicating. The compositions can be administered to a subject having or at risk for gastrointestinal disorders related to immaturity of the immune system, infection or disease.Type: GrantFiled: April 6, 2021Date of Patent: October 3, 2023Assignee: H.J. Heinz Company Brands LLCInventors: Andrea Budelli, Francesca Romana Fasano, Miryam Terzano, Lorenzo Bramati
-
Patent number: 11109603Abstract: The present application relates to compositions and methods for modulation of the mucosal immune system. The compositions include foods fermented by the probiotic organism, Lactobacillus paracasei CBA L74 (International Depository Accession Number LMG P-24778). Alternatively, the compositions can include L. paracasei CBA L74 and a physiologically acceptable carrier. In some embodiments, the L. paracasei CBA L74 can be non-replicating. The compositions can be administered to a subject having or at risk for gastrointestinal disorders related to immaturity of the immune system, infection or disease.Type: GrantFiled: March 21, 2019Date of Patent: September 7, 2021Assignee: H.J. Heinz Company Brands LLCInventors: Andrea Budelli, Francesca Fasano, Miryam Terzano, Lorenzo Bramati
-
Publication number: 20210259264Abstract: The present invention features compositions and methods for modulation of the mucosal immune system. The compositions include foods fermented by the probiotic organism, Lactobacillus paracasei CBA L74 (International Depository Accession Number LMG P-24778). Alternatively the compositions can include L. paracasei CBA L74 and a physiologically acceptable carrier. In some embodiments, the L. paracasei CBA L74 can be non-replicating. The compositions can be administered to a subject having or at risk for gastrointestinal disorders related to immaturity of the immune system, infection or disease.Type: ApplicationFiled: April 6, 2021Publication date: August 26, 2021Inventors: Andrea Budelli, Francesca Romana Fasano, Miryam Terzano, Lorenzo Bramati
-
Patent number: 10993449Abstract: The present application relates to compositions and methods for modulation of the mucosal immune system. The compositions include foods fermented by the probiotic organism, Lactobacillus paracasei CBA L74 (International Depository Accession Number LMG P-24778). Alternatively, the compositions can include L. paracasei CBA L74 and a physiologically acceptable carrier. In some embodiments, the L. paracasei CBA L74 can be non-replicating. The compositions can be administered to a subject having or at risk for gastrointestinal disorders related to immaturity of the immune system, infection or disease.Type: GrantFiled: March 21, 2019Date of Patent: May 4, 2021Assignee: H.J. Heinz Company Brands LLCInventors: Andrea Budelli, Francesca Fasano, Miryam Terzano, Lorenzo Bramati
-
Publication number: 20190281846Abstract: The present application relates to compositions and methods for modulation of the mucosal immune system. The compositions include foods fermented by the probiotic organism, Lactobacillus paracasei CBA L74 (International Depository Accession Number LMG P-24778). Alternatively, the compositions can include L. paracasei CBA L74 and a physiologically acceptable carrier. In some embodiments, the L. paracasei CBA L74 can be non-replicating. The compositions can be administered to a subject having or at risk for gastrointestinal disorders related to immaturity of the immune system, infection or disease.Type: ApplicationFiled: March 21, 2019Publication date: September 19, 2019Inventors: Andrea Budelli, Francesca Fasano, Miryam Terzano, Lorenzo Bramati
-
Patent number: 10251407Abstract: The present application relates to compositions and methods for modulation of the mucosal immune system. The compositions include foods fermented by the probiotic organism, Lactobacillus paracasei CBA L74 (International Depository Accession Number LMG P-24778). Alternatively, the compositions can include L. paracasei CBA L74 and a physiologically acceptable carrier. In some embodiments, the L. paracasei CBA L74 can be non-replicating. The compositions can be administered to a subject having or at risk for gastrointestinal disorders related to immaturity of the immune system, infection or disease.Type: GrantFiled: December 29, 2016Date of Patent: April 9, 2019Assignee: H.J. Heinz Company Brands LLCInventors: Andrea Budelli, Francesca Romana Fasano, Miryam Terzano, Lorenzo Bramati
-
Patent number: 10039296Abstract: The present invention features compositions and methods for modulation of the mucosal immune system. The compositions include foods fermented by the probiotic organism, Lactobacillus paracasei CBA L74 (International Depository Accession Number LMG P-24778). Alternatively the compositions can include L. paracasei CBA L74 and a physiologically acceptable carrier. In some embodiments, the L. paracasei CBA L74 can be non-replicating. The compositions can be administered to a subject having or at risk for gastrointestinal disorders related to immaturity of the immune system, infection or disease.Type: GrantFiled: June 18, 2012Date of Patent: August 7, 2018Assignee: H.J. Heinz Company Brands LLCInventors: Andrea Budelli, Francesca Romana Fasano, Miryam Terzano, Lorenzo Bramati
-
Publication number: 20170202231Abstract: The present application relates to compositions and methods for modulation of the mucosal immune system. The compositions include foods fermented by the probiotic organism, Lactobacillus paracasei CBA L74 (International Depository Accession Number LMG P-24778). Alternatively, the compositions can include L. paracasei CBA L74 and a physiologically acceptable carrier. In some embodiments, the L. paracasei CBA L74 can be non-replicating. The compositions can be administered to a subject having or at risk for gastrointestinal disorders related to immaturity of the immune system, infection or disease.Type: ApplicationFiled: December 29, 2016Publication date: July 20, 2017Inventors: Andrea Budelli, Francesca Romana Fasano, Miryam Terzano, Lorenzo Bramati
-
Publication number: 20140377238Abstract: The present invention features compositions and methods for modulation of the mucosal immune system. The compositions include foods fermented by the probiotic organism, Lactobacillus paracasei CBA L74 (International Depository Accession Number LMG P-24778). Alternatively the compositions can include L. paracasei CBA L74 and a physiologically acceptable carrier. In some embodiments, the L. paracasei CBA L74 can be non-replicating. The compositions can be administered to a subject having or at risk for gastrointestinal disorders related to immaturity of the immune system, infection or disease.Type: ApplicationFiled: June 18, 2012Publication date: December 25, 2014Applicant: H.J. Heinz CompanyInventors: Andrea Budelli, Francesca Romana Fasano, Miryam Terzano, Lorenzo Bramati